PRESS-RELEASE ·Filed Aug 14, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the August 20 earnings release for Q2 2026 financial results, pipeline updates, and any changes to cash runway. The stock has historically been volatile around earnings, but this filing itself contains no new information.
Latest settled — T+20d ⚠ clustered
EVAX ▼ -8.08% at T+20d
NEUTRAL call ✗ call lost -8.08% · α vs SPY -6.09% · entry $3.34 → $3.07
Latest observation: T+31 +22.83% FF3 residual α
T+1d
-6.29%
call -6.29% · α -5.81%
$3.13
settled 7w ago
T+5d
-0.90%
call -0.90% · α +0.47%
$3.31
settled 6w ago
T+20d
-8.08%
call -8.08% · α -6.09%
$3.07
settled 18d ago
T+60d
—
call — · α —
—
in 5w
Price Chart
Loading chart...
Executive Summary
Evaxion announced the date for its Q2 2026 earnings release and conference call on August 20, 2026. No financial results were disclosed in this filing, making it a routine scheduling notice with no immediate market impact.
Key Facts
- Evaxion will report Q2 2026 financial results on August 20, 2026, before Nasdaq open.
- A conference call and webcast are scheduled for the same day at 08:30 EST.
- No financial data or guidance was provided in this filing.
Financial Impact
None — this is a scheduling notice only.
Risk Factors
- Clinical-stage biotech with no approved products and ongoing capital needs.
- Historical stock volatility and negative post-earnings drift per prior reports.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3345275 |
36 reports for EVAX
100% Hit rate best @ T+5▲ +22.94%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $3.07 $3.21 | ▲ +4.56% | ▲ +4.45% | $3.21 (+4.63%) |
Sep 4, 2026 28d ago | 6-K | $3.12 $3.07 | ▲ +1.60% | ▲ +0.39% | $3.21 (−2.96%) |
Aug 20, 2026 6w ago | 6-K | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 20, 2026 6w ago | Press Release | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 17, 2026 6w ago | 6-K | $3.13 $3.40 | ▲ +8.63% | ▲ +9.82% | $3.21 (+2.63%) |
Aug 14, 2026 7w ago | 6-K | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Aug 14, 2026 7w ago | Press Release | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Jul 17, 2026 11w ago | 6-K | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 17, 2026 11w ago | Press Release | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 13, 2026 11w ago | 6-K | $3.02 $3.08 | ▲ +1.82% | ▲ +2.61% | $3.21 (+6.36%) |
Showing 10 of 36
US Market Status
Market Open — Closes in 44m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access